{
    "medicine_id": "0941e2bc7f0061a88293c2d05e833378223ece22",
    "platform_id": "DB00772",
    "metadata": {
        "name": "Malathion 0 005 g 1mL Lotion",
        "composition": "0 005 g 1mL Malathion",
        "clinical_particulars": {
            "therapeutic_indications": "For patients infected with Pediculus humanus capitis head lice and their ova of the scalp hair",
            "contraindications": {
                "disease": "Malathion is slightly toxic via the oral route with reported oral LD sub 50 sub values of 1000 mg kg to greater than 10 000 mg kg in the rat It is also slightly toxic via the dermal route with reported dermal LD sub 50 sub values of greater than 4000 mg kg in rats Moderate poisoning can result in chest tightness difficulty breathing bradycardia tachycardia tremor ataxia blurred vision and confusion Severe life threatening signs include coma seizures respiratory arrest and paralysis Malathion may also be irritating to the skin and eyes",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Malathion is an organophosphate insecticide commonly used to control mosquitos and other flying insects Pharmaceutically malathion is used to eliminate head lice The principal toxicological effect of malathion is cholinesterase inhibition due primarily to malaoxon and to phosphorus thionate impurities",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00975",
                        "description": "The therapeutic efficacy of Malathion can be decreased when used in combination with Dipyridamole"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Malathion"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "Malathion may increase the QTc prolonging activities of Pitolisant"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Lefamulin may increase the QTc prolonging activities of Malathion"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Malathion is combined with Hydroxyzine"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Malathion is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Malathion is combined with Haloperidol"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Malathion"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Malathion can be increased when it is combined with Abametapir"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}